C反应蛋白与白蛋白比值:预测股浅动脉再狭窄的新标志物
本研究分析685例因症状性外周动脉疾病行血管内介入治疗患者的记录,按C反应蛋白与白蛋白比值(CAR)分组,比较高CAR组与低CAR组的再狭窄率、死亡率和截肢率,并评估CAR对再狭窄的预测价值。高CAR组再狭窄率30.2% vs 10.3%、死亡率31.3% vs 12.9%、截肢率9.1% vs 3%,均显著高于低CAR组。CAR是股浅动脉介入术后再狭窄和不良临床结局的独立预测因子。
要点
- 高CAR组再狭窄率30.2% vs 低CAR组10.3%(P < 0.05)。
- 高CAR组死亡率31.3% vs 低CAR组12.9%(P < 0.05)。
- CAR预测再狭窄的AUC为0.659(95%CI 0.611-0.706,P < 0.01)。
核心结论
- CAR是股浅动脉病变行血管内介入治疗患者再狭窄和不良临床结局的独立预测因子。
研究设计与样本
- 分析685例连续因症状性外周动脉疾病行血管内介入治疗患者的记录,按CAR值分为2组,分析每组手术技术方面及后续临床结局。
主要发现
- 高CAR组再狭窄率30.2% vs 低CAR组10.3%(P < 0.05)。
- 高CAR组死亡率31.3% vs 低CAR组12.9%(P < 0.05)。
- 高CAR组下肢截肢率9.1% vs 低CAR组3%(P < 0.05)。
- CAR的ROC曲线下面积(AUC)为0.659(95%CI 0.611-0.706,P < 0.01)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In this study, we aimed to investigate the prognostic value of C-reactive protein (CRP) to albumin ratio (CAR) for predicting restenosis in superficial femoral artery (SFA) lesions and its association with subsequent clinical outcomes in patients undergoing endovascular intervention. METHODS: The records of 685 consecutive patients who underwent endovascular intervention due to symptomatic peripheral artery disease were analyzed. Patients were divided into 2 groups, based on the CAR values. For each group, technical aspects of procedures and subsequent clinical outcomes were analyzed. RESULTS: According to our study, patients with high CAR values had higher rates of restenosis (30.2% vs. 10.3%, P < 0.05) and mortality (31.3% vs. 12.9%, P < 0.05). The rate of lower extremity amputations was also significantly higher in patients with high CAR values compared to those with low CAR values (9.1% vs. 3%, P < 0.05). With respect to Receiver operating characteristic ROC curves of inflammatory markers, the area under the curve (AUC) value of CAR was statistically significant (AUC: 0.659; 95% confidence interval CI: 0.611-0.706; P < 0.01). CONCLUSIONS: Our data showed that CAR is an independent predictor of restenosis and poor clinical outcomes in patients undergoing endovascular intervention.
引用
- Tasbulak O, Duran M, Aktemur T, et al. A Novel Marker Indicating Restenosis in Superficial Femoral Artery: C Reactive Protein to Albumin Ratio. Ann Vasc Surg. 2022. PMID: 35568327. doi:10.1016/j.avsg.2022.04.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。